Only one study analyzed the monitoring of ctDNA in gastric cancers (other than the detection of methylation in cell-free circulating DNA (cfcDNA)), and showed that three out of 10 patients (30%) with TP53 mutations in primary tumors showed detectable TP53 mutation levels in the preoperative setting [24]. Here, TP53 is linked to gastric cancer.